Stay updated on Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, representing a minor update to how the study record is presented.
    Difference
    0.0%
    Check dated 2026-06-08T16:46:15.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's revision label was updated from 3.5.3 to 3.5.4, indicating a newer version of the page. This appears to be a minor metadata update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-05-18T03:52:27.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page’s site release/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:53:14.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T14:31:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Padova, Italy, 35128 was added to the locations list and Padua, Italy, 35128 was removed.
    Difference
    0.0%
    Check dated 2026-04-05T08:04:25.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Location name updated from Napoli, Italy, 80100 to Naples, Italy, 80100; page revision changed from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T02:36:59.000Z thumbnail image

Stay in the know with updates to Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Camidanlumab Tesirine in Hodgkin Lymphoma Clinical Trial page.